Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Democratic Congress May Mean Greater Postmarket Focus, FDA Funding

This article was originally published in The Gray Sheet

Executive Summary

The rise of Reps. John Dingell (D-Mich.) and Henry Waxman (D-Calif.) to top committee positions as a result of the Democrats' takeover of the House in the Nov. 7 elections could mean more attention on device safety issues in the new Congress
Advertisement

Related Content

Tough Investigator And Universal-Coverage Proponent Rep. John Dingell Dead At 92
The New Face Of Key Congressional Committees In the 110th Session
The New Face Of Key Congressional Committees In the 110th Session
CMS Finalizes DRA Imaging Cuts; Stakeholders Hope For Legislative Fix
Report Finds Warning Letters Down, But FDA Says Enforcement Is Still Strong
Report Finds Warning Letters Down, But FDA Says Enforcement Is Still Strong
Advertisement
UsernamePublicRestriction

Register

MT024182

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel